DK1697345T3 - Morpholinylholdige benzimidazoler som inhibitorer af respiratorisk syncytialvirus-replikation - Google Patents
Morpholinylholdige benzimidazoler som inhibitorer af respiratorisk syncytialvirus-replikationInfo
- Publication number
- DK1697345T3 DK1697345T3 DK04817576T DK04817576T DK1697345T3 DK 1697345 T3 DK1697345 T3 DK 1697345T3 DK 04817576 T DK04817576 T DK 04817576T DK 04817576 T DK04817576 T DK 04817576T DK 1697345 T3 DK1697345 T3 DK 1697345T3
- Authority
- DK
- Denmark
- Prior art keywords
- morpholinyl
- inhibitors
- respiratory syncytial
- syncytial virus
- virus replication
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104810 | 2003-12-18 | ||
| US56718204P | 2004-04-30 | 2004-04-30 | |
| EP04105312 | 2004-10-26 | ||
| PCT/EP2004/053620 WO2005058871A1 (en) | 2003-12-18 | 2004-12-20 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1697345T3 true DK1697345T3 (da) | 2008-06-23 |
Family
ID=34704695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04817576T DK1697345T3 (da) | 2003-12-18 | 2004-12-20 | Morpholinylholdige benzimidazoler som inhibitorer af respiratorisk syncytialvirus-replikation |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7449463B2 (da) |
| EP (1) | EP1697345B1 (da) |
| JP (1) | JP4951348B2 (da) |
| KR (1) | KR100967406B1 (da) |
| CN (2) | CN101412709B (da) |
| AP (1) | AP2150A (da) |
| AR (1) | AR046959A1 (da) |
| AT (1) | ATE388950T1 (da) |
| AU (1) | AU2004298460B2 (da) |
| BR (1) | BRPI0417268B8 (da) |
| CA (1) | CA2548668C (da) |
| CY (1) | CY1108142T1 (da) |
| DE (1) | DE602004012448T2 (da) |
| DK (1) | DK1697345T3 (da) |
| EA (1) | EA009876B1 (da) |
| EG (1) | EG25799A (da) |
| ES (1) | ES2303653T3 (da) |
| HK (1) | HK1130799A1 (da) |
| HR (1) | HRP20080245T3 (da) |
| IL (1) | IL175910A (da) |
| ME (1) | ME01042B (da) |
| MX (1) | MXPA06007112A (da) |
| MY (1) | MY143573A (da) |
| NO (1) | NO339314B1 (da) |
| NZ (1) | NZ547479A (da) |
| PL (1) | PL1697345T3 (da) |
| PT (1) | PT1697345E (da) |
| RS (1) | RS50584B (da) |
| SI (1) | SI1697345T1 (da) |
| TW (1) | TWI351401B (da) |
| UA (1) | UA84718C2 (da) |
| WO (1) | WO2005058871A1 (da) |
| ZA (1) | ZA200605894B (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| TWI370820B (en) | 2005-04-27 | 2012-08-21 | Takeda Pharmaceutical | Fused heterocyclic compounds |
| US8034835B2 (en) * | 2005-06-20 | 2011-10-11 | Tibotec Pharmaceuticals Ltd. | 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs |
| BRPI0611744B8 (pt) * | 2005-06-20 | 2021-05-25 | Janssen R & D Ireland | benzimidazóis heterociclilaminoalquila substituída, seu processo de preparação e composição farmacêutica |
| US20120148678A1 (en) | 2010-12-08 | 2012-06-14 | Advanced Technologies And Regenerative Medicine, Llc. | Sustained release of poorly water soluble active compounds |
| TWI650321B (zh) | 2011-10-14 | 2019-02-11 | 美商安比特生物科學公司 | 雜環化合物及其使用方法 |
| UA119050C2 (uk) * | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| JO3637B1 (ar) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
| US10906899B2 (en) | 2016-05-10 | 2021-02-02 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of RSV |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| MX2018014032A (es) | 2017-03-20 | 2019-08-21 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de piruvato cinasa (pkr). |
| TW201932470A (zh) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 具有抗ｒｓｖ活性之吡唑并嘧啶 |
| EP3746444B1 (en) | 2018-01-31 | 2023-09-27 | Janssen Sciences Ireland Unlimited Company | Cycloalkyl substituted pyrazolopyrimidines having activity against rsv |
| EA202092439A1 (ru) | 2018-04-23 | 2021-03-05 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Гетероароматические соединения, обладающие активностью против rsv |
| CN113226356A (zh) | 2018-09-19 | 2021-08-06 | 福马治疗股份有限公司 | 活化丙酮酸激酶r |
| EP3853206B1 (en) | 2018-09-19 | 2024-04-10 | Novo Nordisk Health Care AG | Treating sickle cell disease with a pyruvate kinase r activating compound |
| GB201820751D0 (en) * | 2018-12-19 | 2019-01-30 | Bp Oil Int | Methods for preparing intermediates |
| CA3147397A1 (en) | 2019-07-22 | 2021-01-28 | Lupin Limited | Macrocyclic compounds as sting agonists and methods and uses thereof |
| JP7329239B2 (ja) | 2019-09-20 | 2023-08-18 | 株式会社タマディック | フライトシミュレーター |
| WO2023018560A1 (en) * | 2021-08-13 | 2023-02-16 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE258928T1 (de) * | 1999-06-28 | 2004-02-15 | Janssen Pharmaceutica Nv | Respiratorisches syncytialvirus replikation inhibitoren |
| AP1552A (en) * | 1999-06-28 | 2006-01-17 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors. |
| DE60033859T2 (de) * | 1999-06-28 | 2007-11-08 | Janssen Pharmaceutica N.V. | Hemmer des Respiratorischen Syncytial Virus |
| WO2005058869A1 (en) * | 2003-12-18 | 2005-06-30 | Tibotec Pharmaceuticals Ltd. | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
-
2004
- 2004-12-17 AR ARP040104755A patent/AR046959A1/es active IP Right Grant
- 2004-12-20 AU AU2004298460A patent/AU2004298460B2/en not_active Ceased
- 2004-12-20 CN CN200810166056.9A patent/CN101412709B/zh active Active
- 2004-12-20 AP AP2006003640A patent/AP2150A/xx active
- 2004-12-20 RS RSP-2008/0266A patent/RS50584B/sr unknown
- 2004-12-20 KR KR1020067014047A patent/KR100967406B1/ko active IP Right Grant
- 2004-12-20 EP EP04817576A patent/EP1697345B1/en active Active
- 2004-12-20 ES ES04817576T patent/ES2303653T3/es active Active
- 2004-12-20 JP JP2006544467A patent/JP4951348B2/ja active Active
- 2004-12-20 BR BRPI0417268A patent/BRPI0417268B8/pt not_active IP Right Cessation
- 2004-12-20 PT PT04817576T patent/PT1697345E/pt unknown
- 2004-12-20 AT AT04817576T patent/ATE388950T1/de active
- 2004-12-20 CA CA2548668A patent/CA2548668C/en active Active
- 2004-12-20 SI SI200430732T patent/SI1697345T1/sl unknown
- 2004-12-20 MY MYPI20045259A patent/MY143573A/en unknown
- 2004-12-20 NZ NZ547479A patent/NZ547479A/en not_active IP Right Cessation
- 2004-12-20 MX MXPA06007112A patent/MXPA06007112A/es active IP Right Grant
- 2004-12-20 PL PL04817576T patent/PL1697345T3/pl unknown
- 2004-12-20 CN CNA2004800378255A patent/CN1894237A/zh active Pending
- 2004-12-20 DK DK04817576T patent/DK1697345T3/da active
- 2004-12-20 WO PCT/EP2004/053620 patent/WO2005058871A1/en active Application Filing
- 2004-12-20 DE DE602004012448T patent/DE602004012448T2/de active Active
- 2004-12-20 US US10/563,691 patent/US7449463B2/en active Active
- 2004-12-20 ME MEP-2008-207A patent/ME01042B/me unknown
- 2004-12-20 TW TW093139923A patent/TWI351401B/zh not_active IP Right Cessation
- 2004-12-20 UA UAA200606224A patent/UA84718C2/ru unknown
- 2004-12-20 EA EA200601178A patent/EA009876B1/ru unknown
-
2006
- 2006-05-25 IL IL175910A patent/IL175910A/en active IP Right Grant
- 2006-06-14 EG EGNA2006000561 patent/EG25799A/xx active
- 2006-07-17 ZA ZA2006/05894A patent/ZA200605894B/en unknown
- 2006-07-18 NO NO20063322A patent/NO339314B1/no not_active IP Right Cessation
-
2008
- 2008-06-03 HR HR20080245T patent/HRP20080245T3/xx unknown
- 2008-06-12 CY CY20081100633T patent/CY1108142T1/el unknown
- 2008-06-17 US US12/140,686 patent/US8883837B2/en active Active
-
2009
- 2009-10-13 HK HK09109448.0A patent/HK1130799A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1723136T3 (da) | Piperidinamino-benzimidazol-derivat som inhibitorer af replikation af respiratorisk syncytial virus | |
| DK1697345T3 (da) | Morpholinylholdige benzimidazoler som inhibitorer af respiratorisk syncytialvirus-replikation | |
| NL301090I2 (nl) | Entrectinib, dan wel tautomeren, of farmaceutisch aanvaardbare zouten daarvan | |
| DK2019825T3 (da) | Inhibitorer af human immundefektvirus-replikation | |
| DK1981875T3 (da) | Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase | |
| DK2220076T5 (da) | Inhibitorer af replikationen af humant immundefektvirus | |
| DK2081895T3 (da) | Hydrobenzamidderivater som hæmmere af hsp90 | |
| DK1196408T3 (da) | Inhibitorer af respiratorisk syncytialvirusreplikation | |
| DK1786799T3 (da) | Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase | |
| DK1196410T3 (da) | Inhibitorer af respiratorisk syncytialvirusreplikation | |
| DK2094676T3 (da) | Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater | |
| DK1931350T3 (da) | Administration af inhibitorer af dipeptidylpeptidase | |
| DK2315756T3 (da) | 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase | |
| DK1776136T3 (da) | Behandling af tilstande, der involverer demyelinisering | |
| DE602005023266D1 (de) | Azabenzofuransubstituierte thioharnstoffe als inhibitoren der virusreplikation | |
| DK1954690T3 (da) | Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase | |
| ZA200605893B (en) | Aminobenzimidazones and benzimidazoles as inhibitors of respiratory syncytial virus replication | |
| DK1740534T3 (da) | Fremgangsmåde til rensning af mesotrion | |
| DK2069353T3 (da) | Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus | |
| DK1973563T3 (da) | Fremgangsmåde til oprensning af alfa-1-antitrypsin | |
| DK1697347T3 (da) | 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus | |
| DK1888613T3 (da) | Fremgangsmåde til fremstilling af thiophenglycosidderivater | |
| DK1933829T3 (da) | Fremgangsmåde til bekæmpelse af infektion | |
| DK2081884T3 (da) | Fremgangsmåde til fremstilling af aminer | |
| SI1723136T1 (sl) | Piperidin-amino-benzimidazolni derivati kot inhibitorji replikacije respiratornega sincicijskega virusa |